← Leaderboards
Tze-Chein Wun
Evas Therapeutics, Llc.
$1,985,748
Attributed
$1,985,748
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $727.2K · FY2005–18$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$1,985,748 · 4
By mechanism
R44$1,365,616 · 1
R43$620,132 · 3
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Membrane”
- Dennis R. Burton · Scripps Research Institute$258,610,184
- Barton F Haynes · Duke University$123,162,119
- Ted Ross · University Of Georgia$71,962,304
- Robert M Stroud · University Of California, San Francisco$63,701,163
- Dennis L. Kasper · Harvard Medical School$58,511,900
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$56,839,058
Research focus
MembraneAnticoagulantsBioprocessCoagulation ProcessProductionChimeric ProteinsSurfacePlasmaOperative Surgical ProceduresPre-ClinicalIowaFermentationPhospholipidsArteriesComplexHemorrhageAnnexin A5AcuteAnimalsCoenzymesAnticoagulationEffective TherapyInhibitor/AntagonistCells
Grant awards (5)
Cardioprotection by inhibition of coagulation and inflammation in myocardial infarction$299,999
R43 · FY2018 · HL · contact PI
Novel antithrombotic agents to prevent hemodialysis vascular access failure$638,409
R44 · FY2013 · HL · contact PI
Novel antithrombotic agents to prevent hemodialysis vascular access failure$727,207
R44 · FY2012 · HL · contact PI
Pharmacologic treatment of thromboembolism$167,481
R43 · FY2009 · HL · contact PI
Novel Recombinant Anticoagulant Proteins$152,652
R43 · FY2005 · HL